デフォルト表紙
市場調査レポート
商品コード
1588851

経カテーテル肺動脈弁の世界市場

Transcatheter Pulmonary Valves

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
経カテーテル肺動脈弁の世界市場
出版日: 2024年11月13日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

経カテーテル肺動脈弁の世界市場は2030年までに1億1,500万米ドルに達する見込み

2023年に7,750万米ドルと推定される経カテーテル肺動脈弁の世界市場は、2030年には1億1,500万米ドルに達し、分析期間2023-2030年のCAGRは5.8%で成長すると予測されます。本レポートで分析したセグメントの1つであるバルーン拡張技術は、CAGR 6.2％を記録し、分析期間終了までに7,410万米ドルに達すると予測されます。自己拡張型技術セグメントの成長率は、分析期間中CAGR 5.2%と推定されます。

米国市場は2,050万米ドルと推定、中国はCAGR 9.1％で成長予測

米国の経カテーテル肺動脈弁市場は、2023年に2,050万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 9.1%で推移し、2030年には予測市場規模2,710万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.2%と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の経カテーテル肺動脈弁（TPV）市場- 主要動向と促進要因まとめ

経カテーテル肺動脈弁（TPVs）とは何か？

経カテーテル肺動脈弁（TPVs）は、肺動脈弁疾患、特に先天性心疾患や肺動脈逆流症の患者を治療するために設計された革新的な医療機器です。これらの低侵襲性バルブはカテーテルを介して供給されるため、開心術を必要とせずに機能不全の肺動脈弁を交換することができます。TPVは、患者に侵襲の少ない選択肢を提供し、回復時間を短縮し、心臓弁障害の管理における全体的な転帰を改善するため、心臓治療において不可欠です。

TPVの需要は、先天性心疾患の有病率の増加や、しばしば心臓の変性疾患を経験する高齢化により急増しています。カテーテルベースの技術が進化を続ける中、TPVの採用は現代の心臓手術に不可欠なものとなっており、手術のリスクを最小限に抑え、患者の快適性を高めながら、肺動脈弁障害の効果的な治療を可能にしています。

経カテーテル肺動脈弁はどのように患者の治療成績とQOLを向上させるのでしょうか？

経カテーテル肺動脈弁は、従来の外科的弁置換術に代わる、より低侵襲な治療法を提供することで、患者の予後と生活の質を向上させます。TPV植え込み術の低侵襲性は、患者が経験する外傷が少ないことを意味し、入院期間の短縮と回復時間の短縮をもたらします。これは特に、年齢やその他の健康上の合併症のために開心術の適応とならないハイリスク患者にとって有益です。

さらに、TPVは運動不耐性、疲労、心不全などの肺動脈弁機能不全に伴う症状を効果的に緩和します。適切な弁機能を回復させることで、これらの装置は患者の全体的な健康と生活の質を大幅に向上させることができます。多くの場合、患者はより早く通常の活動に戻ることができ、精神的・身体的な幸福の向上につながります。さらに、TPV手術の長期的な成功率は、患者の満足度を持続させ、慢性心疾患のより良い管理に貢献します。

技術の進歩は、経カテーテル肺動脈弁の開発をどのように形成しているか？

技術の進歩は、経カテーテル肺動脈弁のデザイン、素材、機能性を大きく変え、その有効性と信頼性を高めています。大きな技術革新の一つは、TPVの耐久性と性能を向上させる新しい生体適合性材料の開発です。これらの材料は、心臓のダイナミックな環境に耐えるように設計されており、同時に、長期間にわたって弁機能を損なう可能性のある血栓症や石灰化のリスクを最小限に抑えています。

もう一つの重要な進歩は、カテーテルデリバリーシステムの改良であり、これにより手技中にTPVをより正確に設置することができるようになった。X線透視や心エコーなどの画像技術の向上により、弁の位置がリアルタイムで可視化され、正確性が向上し、手技合併症が減少しました。これらの進歩により、TPV植え込み術の成功率が向上し、より幅広い患者がこの手技を受けられるようになった。

さらに、現在進行中の研究開発では、様々な患者の体格や状態に対応できるようにTPVの設計を改善することに重点を置いています。個々の患者の特定のニーズに適応できるカスタマイズ可能なバルブの設計が研究されており、より効果的な治療オプションが可能になっています。こうした技術的進歩は、経カテーテル肺動脈弁の性能を高めるだけでなく、インターベンショナル・カーディオロジー分野での用途を拡大します。

経カテーテル肺動脈弁市場の成長を促進する要因は？

経カテーテル肺動脈弁市場の成長は、先天性心疾患の有病率の増加、高齢化人口の増加、医療技術の進歩、低侵襲処置への嗜好の高まりなど、いくつかの要因によって牽引されています。特に先天性心疾患を持つ小児および成人集団における肺動脈弁疾患の罹患率の上昇は、TPVのような効果的な治療ソリューションに対する大きな需要を生み出しています。

高齢者は心臓弁の交換や修復が必要な変性疾患を経験する可能性が高いため、高齢化も市場の成長に寄与しています。ヘルスケアプロバイダーが患者の転帰と生活の質の向上に重点を置く中、TPVは低侵襲性で回復時間が短いため、好ましい選択肢になりつつあります。

バルブのデザイン、送達システム、画像技術の改善を含む医療技術の進歩により、TPV手術はより安全で効果的なものとなっています。このことがヘルスケアプロバイダーにこれらの技術をより広く採用することを促し、市場の成長をさらに促進しています。さらに、患者中心の治療が重視されるようになり、より侵襲の少ない治療法が求められるようになったことで、心臓治療のプロトコルにTPVを取り入れる医療機関が増えています。

アジア太平洋とラテンアメリカの新興市場では、ヘルスケア・インフラと心臓治療への投資が増加しており、TPV市場に新たな機会が生まれています。継続的な技術革新、心血管治療における用途の拡大、効果的で低侵襲なソリューションに対する需要の高まりにより、経カテーテル肺動脈弁市場は、進化する業界ニーズと心臓技術の進歩に牽引され、持続的な成長を遂げる態勢が整っています。

調査対象企業の例（全42件）

  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Cryolife Inc.
  • Direct Flow Medical Inc.
  • Edward Lifesciences Corporation
  • Jenavalve Technology Inc.
  • Livanova plc
  • Medtronic
  • St. Jude Medical
  • Venus Medtech

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22971

Global Transcatheter Pulmonary Valves Market to Reach US$115.0 Million by 2030

The global market for Transcatheter Pulmonary Valves estimated at US$77.5 Million in the year 2023, is expected to reach US$115.0 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Balloon-Expanded Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$74.1 Million by the end of the analysis period. Growth in the Self-Expanded Technology segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.5 Million While China is Forecast to Grow at 9.1% CAGR

The Transcatheter Pulmonary Valves market in the U.S. is estimated at US$20.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$27.1 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Transcatheter Pulmonary Valves (TPVs) Market - Key Trends & Drivers Summarized

What Are Transcatheter Pulmonary Valves (TPVs) & Why Are They Essential in Cardiac Care?

Transcatheter pulmonary valves (TPVs) are innovative medical devices designed to treat patients with pulmonary valve disease, particularly those with congenital heart defects or pulmonary regurgitation. These minimally invasive valves are delivered via a catheter, allowing for the replacement of malfunctioning pulmonary valves without the need for open-heart surgery. TPVs are essential in cardiac care as they provide a less invasive option for patients, reduce recovery times, and improve overall outcomes in managing heart valve disorders.

The demand for TPVs has surged due to the increasing prevalence of congenital heart defects and the aging population, which often experiences degenerative heart conditions. As advancements in catheter-based technologies continue to evolve, the adoption of TPVs has become an integral part of modern cardiac procedures, allowing for effective treatment of pulmonary valve disorders while minimizing surgical risks and enhancing patient comfort.

How Do Transcatheter Pulmonary Valves Improve Patient Outcomes & Quality of Life?

Transcatheter pulmonary valves improve patient outcomes and quality of life by offering a less invasive alternative to traditional surgical valve replacement. The minimally invasive nature of TPV implantation means that patients experience less trauma, resulting in shorter hospital stays and faster recovery times. This is particularly beneficial for high-risk patients who may not be suitable candidates for open-heart surgery due to age or other health complications.

Additionally, TPVs provide effective relief from symptoms associated with pulmonary valve dysfunction, such as exercise intolerance, fatigue, and heart failure. By restoring proper valve function, these devices can significantly enhance patients' overall health and quality of life. Patients are often able to return to normal activities more quickly, leading to improved mental and physical well-being. Furthermore, the long-term success rates of TPV procedures contribute to sustained patient satisfaction and better management of chronic heart conditions.

How Are Technological Advancements Shaping the Development of Transcatheter Pulmonary Valves?

Technological advancements have significantly transformed the design, materials, and functionality of transcatheter pulmonary valves, enhancing their effectiveness and reliability. One major innovation is the development of new biocompatible materials that improve the durability and performance of TPVs. These materials are designed to withstand the dynamic environment of the heart while minimizing the risk of thrombosis and calcification, which can compromise valve function over time.

Another significant advancement is the refinement of catheter delivery systems, which allows for more precise placement of TPVs during procedures. Enhanced imaging technologies, such as fluoroscopy and echocardiography, provide real-time visualization of the valve's positioning, improving accuracy and reducing procedural complications. These advancements have led to a higher success rate in TPV implantations and have made the procedure more accessible to a broader range of patients.

Additionally, ongoing research and development efforts are focused on improving the design of TPVs to accommodate various patient anatomies and conditions. Customizable valve designs that can adapt to the specific needs of individual patients are being explored, allowing for more effective treatment options. These technological advancements not only enhance the performance of transcatheter pulmonary valves but also expand their applications in the field of interventional cardiology.

What Factors Are Driving Growth in the Transcatheter Pulmonary Valves Market?

The growth in the transcatheter pulmonary valves market is driven by several factors, including the increasing prevalence of congenital heart defects, the rise in the aging population, advancements in medical technology, and the growing preference for minimally invasive procedures. The rising incidence of pulmonary valve diseases, particularly among pediatric and adult populations with congenital heart conditions, has created a significant demand for effective treatment solutions like TPVs.

The aging population is also contributing to market growth, as older adults are more likely to experience degenerative heart valve diseases that necessitate replacement or repair. As healthcare providers focus on improving patient outcomes and quality of life, TPVs are becoming a preferred option due to their minimally invasive nature and shorter recovery times.

Advancements in medical technology, including improvements in valve design, delivery systems, and imaging techniques, have made TPV procedures safer and more effective. This has encouraged healthcare providers to adopt these technologies more widely, further driving market growth. Additionally, the increasing emphasis on patient-centered care and the demand for less invasive treatment options are prompting more institutions to incorporate TPVs into their cardiac care protocols.

Emerging markets in Asia-Pacific and Latin America are witnessing increased investment in healthcare infrastructure and cardiac care, creating new opportunities for the TPV market. With ongoing innovations, expanding applications in cardiovascular treatments, and rising demand for effective and minimally invasive solutions, the transcatheter pulmonary valves market is poised for sustained growth, driven by evolving industry needs and advancements in cardiac technology.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Cryolife Inc.
  • Direct Flow Medical Inc.
  • Edward Lifesciences Corporation
  • Jenavalve Technology Inc.
  • Livanova plc
  • Medtronic
  • St. Jude Medical
  • Venus Medtech

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Transcatheter Pulmonary Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Congenital Heart Diseases Drives TPV Market Growth
    • Increasing Use in Minimally Invasive Cardiology Sets the Stage for TPV Adoption
    • Technological Advancements in Valve Design Strengthen Market Expansion
    • Growing Use in Pediatric Cardiology Expands Addressable Market for TPVs
    • Trend Toward Catheter-Based Treatments Supports TPV Demand
    • Emergence of Bio-Compatible Valves Bodes Well for Market Growth
    • Increasing Applications in Heart Valve Replacement Drive TPV Market
    • Rising Demand in Cardiac Centers Expands Market for Transcatheter Pulmonary Valves
    • Growing Demand in Geriatric Cardiology Supports TPV Market
    • Trend Toward Valve-in-Valve Procedures Drives TPV Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Pulmonary Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transcatheter Pulmonary Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Balloon-Expanded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Balloon-Expanded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Balloon-Expanded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Self-Expanded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Self-Expanded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Self-Expanded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Tissue Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Tissue Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Tissue Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Transcatheter Pulmonary Valves Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • JAPAN
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • CHINA
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • EUROPE
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Transcatheter Pulmonary Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Transcatheter Pulmonary Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • FRANCE
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • GERMANY
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Spain 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: Russia 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Australia Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 148: Australia 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • INDIA
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 155: India Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 156: India Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 157: India 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 160: India 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 165: South Korea Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 166: South Korea 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 183: Latin America Historic Review for Transcatheter Pulmonary Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 184: Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 194: Argentina Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Argentina Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 196: Argentina 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Transcatheter Pulmonary Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 242: Iran Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Iran Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 244: Iran 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 251: Israel Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Israel Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 253: Israel 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Saudi Arabia Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 262: Saudi Arabia 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 269: UAE Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 270: UAE Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 271: UAE 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Rest of Middle East Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 280: Rest of Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030
  • AFRICA
    • Transcatheter Pulmonary Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 287: Africa Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Africa Historic Review for Transcatheter Pulmonary Valves by Technology - Balloon-Expanded and Self-Expanded Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 289: Africa 16-Year Perspective for Transcatheter Pulmonary Valves by Technology - Percentage Breakdown of Value Sales for Balloon-Expanded and Self-Expanded for the Years 2014, 2024 & 2030
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Transcatheter Pulmonary Valves by Material Type - Tissue Engineered and Synthetic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Transcatheter Pulmonary Valves by Material Type - Percentage Breakdown of Value Sales for Tissue Engineered and Synthetic for the Years 2014, 2024 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Transcatheter Pulmonary Valves by End-Use - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Transcatheter Pulmonary Valves by End-Use - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

IV. COMPETITION